The U.S. Weight Loss & Diet Control Market: Commercial (non-medical) Programs & Products

The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs. The large commercial chains have been hurt the most since 2022. Commercial weight loss firms lost $2 billion in sales to the GLP-1 drugs market. The business has gone virtual, and some competitors have added the GLP-1 drugs to their programs to position themselves for a new future.

However, some commercial markets have held up well. Diet soft drinks have shown surprising strength, and high protein meal replacements have been positioned as an adjunct to the weight loss drugs. The weight loss apps market is growing strongly. The ranks of commercial weight loss centers have been thinned, and franchising is all but dead as a growth model.

This Marketdata report is a completely updated analysis of the U.S. weight loss market, with a heavy focus on commercial weight loss centers/services – how they have been affected by and are responding to the popular GLP-1 drugs. This is the most comprehensive investigation of the U.S. commercial weight loss market published by anyone worldwide.

Included… dollar value & growth rates of all major commercial weight loss market segments (early 1980s to 2024 and 2025 & 2028 forecasts), latest market trends and company developments, status reports for: diet soft drinks, artificial sweeteners, commercial weight loss centers, multi-level marketing diet plans, retail and MLM meal replacements and weight loss supplements, and low-cal frozen entrees. Analysis of the medical weight loss programs market and competition from MDs, hospitals, medical clinic chains, and telehealth.

The report includes a 35-year revenue analysis of the market through past recessions and fad diet cycles, plus weight loss center franchising, and extensive national/state commercial centers’ operating ratios. Rankings & revenues of top commercial chains, brand sales, and a Reference Directory. Competitor profiles for: Weight Watchers, Jenny Craig, NutriSystem, Medifast, Herbalife, Noom, MyFitness Pal, Slim-Fast (Glanbia), Simply Good Foods (Atkins Nutritionals), Slimgenics, Profile by Sanford, BeachBody, Metabolic Research, Visalis Life Sciences, Isagenix, Shaklee, AMWAY (Quixtar), and Nu-Skin.

New for this edition:

• Effects of the soaring GLP-1 drugs market and medical weight loss programs
• 2023-2024 market performance, 2025 & 2028 Forecasts
• Rankings/revenues of the leading competitors
• The franchising slowdown – why retail centers are disappearing

Show more